Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
03/2008
03/13/2008CA2663091A1 Modulators of interleukin-1 receptor-associated kinase
03/13/2008CA2662705A1 Hypertension-ameliorating agent
03/13/2008CA2662112A1 Imidazole derivatives and their use as cannabinoid type 2 (cb2) receptor modulators
03/13/2008CA2662031A1 Heteroaryl derivatives as protein kinase inhibitors
03/13/2008CA2661975A1 Benzothiazepines as antagonists for the mitochondrial sodium-calcium exchanger
03/13/2008CA2661878A1 Anti-activin a antibodies and uses thereof
03/13/2008CA2661404A1 Pharmaceutical combinations for lipid management and in the treatment of atherosclerosis and hepatic steatosis
03/13/2008CA2661315A1 Pyridin-3-yl derivatives as immunomodulating agents
03/13/2008CA2661308A1 Neukinase, a downstream protein of neuregulin
03/13/2008CA2661105A1 Pyridin-4-yl derivatives as immunomodulating agents
03/12/2008EP1897880A1 1,3-benzothiazinone derivative and use thereof
03/12/2008EP1897558A1 Solid preparation
03/12/2008EP1897554A1 Method for the manufacture of a medicament for treating hemorrhagic stroke
03/12/2008EP1897541A2 Hypoglycemic agent
03/12/2008EP1897441A1 TGF-alpha polypeptides, functional fragments and methods of use therefor
03/12/2008EP1896477A1 Aspartyl protease inhibitors
03/12/2008EP1896459A1 Novel 2-azetidinone derivatives as cholesterol absorption inhibitors for the treatment of hyperlipidaemic conditions
03/12/2008EP1896458A1 New 2-azetidinone derivatives as cholesterol absorption inhibitors for the treatment of hyperlipidaemic conditions
03/12/2008EP1896457A1 New 2-azetidinone derivatives useful in the treatment of hyperlipidaemic conditions
03/12/2008EP1896455A2 Process for the preparation of tetrazolyl compounds
03/12/2008EP1896430A2 The preparation and use of compounds as aspartyl protease inhibitors
03/12/2008EP1896427A2 Novel 2-(phenylamino)benzimidazole derivatives and their use as modulators of small-conductance calcium-activated potassium channels
03/12/2008EP1896417A1 Linear urea mimics antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
03/12/2008EP1896416A1 Substituted heterocycles, their use as medicament, and pharmaceutical preparations comprising them
03/12/2008EP1896410A1 Novel 2-azetidinone derivatives as cholesterol absorption inhibitors for the treatment of hyperlipidaemic conditions
03/12/2008EP1896409A1 Novel 2-azetidinone derivatives as cholesterol absorption inhibitors useful for the treatment of hyperlipidaemic conditions
03/12/2008EP1896408A1 New 2-azetidinone derivatives for the treatment of hyperlipidaemic diseases
03/12/2008EP1896136A2 Compositions having an activity of ameliorating a reduced higher brain function resulting from organic brain lesions
03/12/2008EP1896074A1 Pharmaceutical compositions for treating or preventing coronary artery disease
03/12/2008EP1896053A1 Pharmaceutical composition comprising fgf18 and il-1 antagonist and method of use
03/12/2008EP1896032A2 The preparation and use of compounds as protease inhibitors
03/12/2008EP1896028A2 Sustained release formulation and dosing schedules of leukotriene synthesis inhibitor for human therapy
03/12/2008EP1896013A1 Nuclear receptors agonists for treatment of atherosclerosis and/or related cardiovascular disease
03/12/2008EP1896008A2 Inducing peripheral blood vessel vasodilation
03/12/2008EP1539693B1 Cannabinoid receptor agonists
03/12/2008EP1534275B1 Acylamino-substituted heteroaromatic compounds and their use as pharmaceuticals
03/12/2008EP1495009B1 Cyanamides useful as reversible inhibitors of cysteine proteases
03/12/2008EP1414809B1 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation
03/12/2008EP1128830B1 Reversing advanced glycosylation cross-links using heterocyclic-substituted thiazolium salts
03/12/2008EP0973538B1 Modified proteins which bind extracellular matrix components
03/12/2008EP0833659B1 Therapeutic fragments of von willebrand factor
03/12/2008CN101142219A Pyrazolopyrimidine derivatives or pharmaceutically acceptable salts thereof
03/12/2008CN101142215A Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith
03/12/2008CN101141997A Cooperation thermal stabilization oil medium containing eicosapentaenoic acid(EPA) and docosahexenoic acid
03/12/2008CN101141977A Use of the Mst protein for the treatment of a thromboembolic disorder
03/12/2008CN101141965A Pharmaceutical composition and method for regenerating myofibers in the treatment of muscle injuries
03/12/2008CN101141964A Methods and compositions for treating diabetes, metabolic syndrome and other conditions
03/12/2008CN101139625A Ace inhibitory peptides from plant materials
03/12/2008CN101139393A KDR peptides and vaccines containing the same
03/12/2008CN101139392A KDR peptides and vaccines containing the same
03/12/2008CN101139345A Polymorphic forms of 1-'4-(5-cyanoindol-3-yl)butyl-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride
03/12/2008CN101139306A Novel diphenyl azetidinone with improved physiological characteristics, corresponding production method, medicaments containing said compound and use of the latter
03/12/2008CN101138635A Fibrin glue vasodilation agent sustained-release long-acting composition
03/12/2008CN101138633A BCG vaccine for preventing and reversing fleshy and fleshy cardiovascular organization
03/12/2008CN101138630A Fibrin glue composition for repairing nerve damage and methods thereof
03/12/2008CN101138601A Preparation method of Chinese herb medicine compound for treating coronary heart disease
03/12/2008CN101138596A Prescription of traditional Chinese medicine hyssop health lozenge
03/12/2008CN101138593A Preparation method of Chinese medicine unction and emplastrum for treating external hemorrhoid (ancient ink ointment for curing piles )
03/12/2008CN101138578A Application of eucommia lignans and extract thereof in the preventing and controlling of diabetes complication
03/12/2008CN101138555A Application of octacosanol in the preparation of medicament for treating and preventing hypoxic pulmonary hypertension
03/12/2008CN101138545A Clathrate compound containing ginsenoside Rg2 and method of preparing the same
03/12/2008CN101138374A Cortex encomia bag tea particles and method of preparing the same
03/12/2008CN100374440C Spirosubstituted piperidines as selective melanin concentrating hormone receptor antagonists for the treatment of obesity
03/12/2008CN100374435C Substd. pyridines and pyridazines with angiogenesis inhibiting activity
03/12/2008CN100374422C Crystalline forms of pitavastatin calcium
03/12/2008CN100374420C Indolamid derivatives which possess glycogenphosphorylase inhibitory activity
03/12/2008CN100374161C Triacetin as a transdermal penetration enhancer
03/12/2008CN100374158C application of agent for lowering the cell ATP level in preparing medicine
03/12/2008CN100374153C Use of GLP-1 or analogs in treatment of myocardial infraction
03/12/2008CN100374143C Gastrodia freeze dried powder injection for intravenous injection and its preparation technology
03/12/2008CN100374130C Stasis expelling vessel freeing drip pill
03/12/2008CN100374126C Capsule for treating myocardial strain, angina pectoris and arteriosclerosis and its preparing method
03/12/2008CN100374120C Powder of flenabane and its preparation method as well as application in making drugs
03/12/2008CN100374119C Pseudo-ginseng saponin oral disintegration tablet and preparing method
03/12/2008CN100374113C Hypotensor composition
03/12/2008CN100374107C Preparation of honokiol, magnolol or their admixture and usage in preparing medication for treating cardiovascular and cerebrovascular diseases
03/11/2008US7342132 Formoterol tartrate process and polymorph
03/11/2008US7342125 Administering derivatives of Kauranoic acid; cachexia, analgesics, in treating immune disorders, as anti-cancer and anti-tumor agents, otitis media, sinusitis, antidiabetic agent
03/11/2008US7342120 Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms
03/11/2008US7342115 Binding antagonist and arylpyridine for antiinflammatory agents, cardiovascular disorders and antagonist or agonist and for immunology
03/11/2008US7342106 Human antihuman MCP-1 antibody and antibody fragment thereof
03/11/2008US7342034 Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function
03/11/2008US7342032 Psychiatric and neurological disorders; cannabinoid (cb1) receptor; such as 4-(4-Chlorophenyl)-5-(2,4-dichlorophenyl)-N-(1-piperidinyl)thiazole-2-carboxamide
03/11/2008US7342029 Substituted indoles
03/11/2008US7342022 Compounds in the treatment of dementia related diseases, Alzheimer's Disease and conditions associated with glycogen synthase kinase-3
03/11/2008US7342021 Phosphodiesterase 4 inhibitors
03/11/2008US7342020 Effective against MMP 9 and 13; arthritis, atherosclerosis; synthesis
03/11/2008US7342019 5, 6-diaryl-pyrazine-2-amide derivatives as CB1 antagonists
03/11/2008US7342017 Vanilloid Receptor 1 and metabotropic glutamate receptor 1 inhibitors; inhibition of capsaicin-induced or PH-induced activation of vanilloid receptors; antidepressant; anxiolytic agent; analgesics; addictive disorders; antiemetic agent
03/11/2008US7341999 Povidone-containing carriers for polypeptide growth factors
03/11/2008US7341996 Endothelial growth factor for use as diagnostic and preventative tool in treatment of cell proliferative disorders
03/11/2008US7341995 Use of SARP-1 for the treatment and/or prevention of scleroderma
03/11/2008US7341871 Recombinant expression vector comprising promoter sequence, age regulatory sequence; can use in treatment of age-related and liver diseases; operably linking nucleic acid sequence, promoter sequence, and age regulatory sequences to produce a transgene, introducing into cell
03/11/2008US7341866 Gene expression patterns; diagnosis, therapy disease
03/11/2008US7341730 Inhibitors of angiogenesis and tumor growth
03/11/2008US7341716 Solidifying mass in an ionic fluid- containing bodily cavity using polymer comprising 2-cyanoacrylate monomer
03/11/2008CA2402336C Concentrated solutions of carvedilol
03/11/2008CA2335104C Arylalkanoylpyridazines
03/11/2008CA2310664C Substituted 2-aminoacetamides and the use thereof
03/11/2008CA2192764C Integrin receptor antagonists
1 ... 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 578 579 ... 1595